Tocqueville Asset Management’s Inovio Pharmaceuticals INO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-667
| Closed | -$216K | – | 665 |
|
|
2020
Q2 | $216K | Sell |
667
-1,541
| -70% | -$499K | ﹤0.01% | 618 |
|
|
2020
Q1 | $197K | Sell |
2,208
-1,650
| -43% | -$147K | ﹤0.01% | 598 |
|
|
2019
Q4 | $153K | Sell |
3,858
-834
| -18% | -$33.1K | ﹤0.01% | 711 |
|
|
2019
Q3 | $115K | Sell |
4,692
-1,333
| -22% | -$32.7K | ﹤0.01% | 737 |
|
|
2019
Q2 | $213K | Buy |
6,025
+1,000
| +20% | +$35.4K | ﹤0.01% | 734 |
|
|
2019
Q1 | $225K | Buy |
+5,025
| New | +$225K | ﹤0.01% | 716 |
|
|
2018
Q3 | – | Sell |
-2,458
| Closed | -$116K | – | 836 |
|
|
2018
Q2 | $116K | Hold |
2,458
| – | – | ﹤0.01% | 807 |
|
|
2018
Q1 | $139K | Sell |
2,458
-1,950
| -44% | -$110K | ﹤0.01% | 805 |
|
|
2017
Q4 | $218K | Buy |
+4,408
| New | +$218K | ﹤0.01% | 750 |
|
|
2017
Q1 | – | Sell |
-1,750
| Closed | -$146K | – | 817 |
|
|
2016
Q4 | $146K | Sell |
1,750
-542
| -24% | -$45.2K | ﹤0.01% | 772 |
|
|
2016
Q3 | $256K | Sell |
2,292
-3,675
| -62% | -$410K | ﹤0.01% | 736 |
|
|
2016
Q2 | $662K | Buy |
5,967
+100
| +2% | +$11.1K | 0.01% | 577 |
|
|
2016
Q1 | $613K | Buy |
5,867
+217
| +4% | +$22.7K | 0.01% | 590 |
|
|
2015
Q4 | $456K | Buy |
5,650
+1,292
| +30% | +$104K | 0.01% | 682 |
|
|
2015
Q3 | $302K | Sell |
4,358
-292
| -6% | -$20.2K | ﹤0.01% | 805 |
|
|
2015
Q2 | $455K | Buy |
4,650
+1,233
| +36% | +$121K | 0.01% | 740 |
|
|
2015
Q1 | $335K | Sell |
3,417
-416
| -11% | -$40.8K | ﹤0.01% | 787 |
|
|
2014
Q4 | $422K | Sell |
3,833
-917
| -19% | -$101K | ﹤0.01% | 739 |
|
|
2014
Q3 | $561K | Buy |
4,750
+3,052
| +180% | +$360K | 0.01% | 592 |
|
|
2014
Q2 | $220K | Hold |
1,698
| – | – | ﹤0.01% | 945 |
|
|
2014
Q1 | $271K | Buy |
+1,698
| New | +$271K | ﹤0.01% | 726 |
|